Hims & Hers Health (HIMS) Invested Capital (2019 - 2025)
Hims & Hers Health (HIMS) posted Invested Capital of $3.6 million for Q4 2025, down 50.81% sequentially from $7.4 million in Q1 2024.
Hims & Hers Health (HIMS) Invested Capital (2019 - 2025) Analysis & Trends
Hims & Hers Health has reported Invested Capital for 7 years, with the latest figure at $3.6 million in Q4 2025.
- Quarterly Invested Capital changed N/A year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $3.6 million (changed N/A YoY) and the FY2025 annual result came in at $3.6 million, changed N/A from the prior year.
- Invested Capital retreated to $3.6 million in Q4 2025 per HIMS's latest filing, from $7.4 million in the prior quarter.
- Over five years, Invested Capital peaked at $42.8 million in Q4 2021 and troughed at $3.6 million in Q4 2025.
- A 5-year average of $13.5 million and a median of $10.2 million in 2022 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2021 and 2023: Invested Capital surged 5643.71% in 2021, then sank 63.18% in 2023.
- Over 5 years, Invested Capital stood at $42.8 million in 2021, then slumped by 69.72% to $13.0 million in 2022, then sank by 42.86% to $7.4 million in 2023, then changed by 0.0% to $7.4 million in 2024, then plunged by 50.81% to $3.6 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $3.6 million, $7.4 million, and $7.4 million for Q4 2025, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Hims & Hers Health | 7.50 Bn | 6.66 Bn | 480.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.65 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 6.86 Mn |
| Jun 30, 2023 | 4.78 Mn |
| Sep 30, 2022 | 12.97 Mn |
| Jun 30, 2022 | 12.97 Mn |
| Mar 31, 2022 | 12.97 Mn |
| Dec 31, 2021 | 42.83 Mn |
| Sep 30, 2021 | 23.21 Mn |
| Sep 30, 2020 | 404,007.00 |
| Jun 30, 2020 | 495,355.00 |
| Mar 31, 2020 | 449,378.00 |
| Dec 31, 2019 | 427,503.00 |
| Jun 30, 2019 | 56,883.00 |